ARCHIVES

Lederle Scientists Report Powerful New Anticancer Agent

This article is from The Cancer Letter archive.

Vol. 13 No. 31 | July 31, 1987

Download PDF Visit The Full Archive

Related Articles

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

November 27, 1998

Senate Passes NIH Reauthorization 87-10; $2.5 Bil. Auhtority For NCI, New Line Items

April 10, 1992

NCI Programs: Report Calls for Expansion of Colorectal Cancer Research

April 28, 2000

Lagging Government Salaries Spur NCI Turnover Among Senior Staff, Threaten Cancer Program

September 5, 1975

Shorter Hospital Stay After Robot-Assisted Surgeries

February 27, 2009

Clinical Trials, Centers Would Be First In Line For Money Added To Budget, Broder Tells Congress

March 31, 1989